These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 19712714)
21. Polymeric nanoparticles containing taxanes enhance chemoradiotherapeutic efficacy in non-small cell lung cancer. Jung J; Park SJ; Chung HK; Kang HW; Lee SW; Seo MH; Park HJ; Song SY; Jeong SY; Choi EK Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):e77-83. PubMed ID: 22795728 [TBL] [Abstract][Full Text] [Related]
22. A microemulsion co-loaded with Schizandrin A-docetaxel enhances esophageal carcinoma treatment through overcoming multidrug resistance. Su X; Gao C; Shi F; Feng X; Liu L; Qu D; Wang C Drug Deliv; 2017 Nov; 24(1):10-19. PubMed ID: 28155336 [TBL] [Abstract][Full Text] [Related]
23. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles. Liu Q; Li R; Zhu Z; Qian X; Guan W; Yu L; Yang M; Jiang X; Liu B Int J Pharm; 2012 Jul; 430(1-2):350-8. PubMed ID: 22525076 [TBL] [Abstract][Full Text] [Related]
24. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles. Tong SW; Xiang B; Dong DW; Qi XR Int J Pharm; 2012 Sep; 434(1-2):413-9. PubMed ID: 22698861 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex Ghassami E; Varshosaz J; Jahanian-Najafabadi A; Minaiyan M; Rajabi P; Hayati E Int J Nanomedicine; 2018; 13():493-504. PubMed ID: 29416331 [TBL] [Abstract][Full Text] [Related]
27. Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity. Wang L; Liu Z; Liu D; Liu C; Juan Z; Zhang N Int J Pharm; 2011 Jul; 413(1-2):194-201. PubMed ID: 21540085 [TBL] [Abstract][Full Text] [Related]
28. Synthesis, characterization and antitumor evaluation of CMCS-DTX conjugates as novel delivery platform for docetaxel. Liu F; Feng L; Zhang L; Zhang X; Zhang N Int J Pharm; 2013 Jul; 451(1-2):41-9. PubMed ID: 23608199 [TBL] [Abstract][Full Text] [Related]
29. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Liu D; Liu Z; Wang L; Zhang C; Zhang N Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845 [TBL] [Abstract][Full Text] [Related]
30. Nano-sized assemblies of a PEG-docetaxel conjugate as a formulation strategy for docetaxel. Liu J; Zahedi P; Zeng F; Allen C J Pharm Sci; 2008 Aug; 97(8):3274-90. PubMed ID: 18064681 [TBL] [Abstract][Full Text] [Related]
31. The antitumor effect of novel docetaxel-loaded thermosensitive micelles. Liu B; Yang M; Li R; Ding Y; Qian X; Yu L; Jiang X Eur J Pharm Biopharm; 2008 Jun; 69(2):527-34. PubMed ID: 18359617 [TBL] [Abstract][Full Text] [Related]
32. PEI-derivatized fullerene drug delivery using folate as a homing device targeting to tumor. Shi J; Zhang H; Wang L; Li L; Wang H; Wang Z; Li Z; Chen C; Hou L; Zhang C; Zhang Z Biomaterials; 2013 Jan; 34(1):251-61. PubMed ID: 23069706 [TBL] [Abstract][Full Text] [Related]
33. Transarterial chemoembolization using docetaxel-loaded phytantriol cubic phase precursor for the treatment of hepatocellular carcinoma. Han K; Wang Z; Peng X; Chen B; Wen X; Dong Y; Wu C J Pharm Sci; 2011 Jun; 100(6):2240-7. PubMed ID: 21491445 [TBL] [Abstract][Full Text] [Related]
34. Interferon-alpha improves docetaxel antitumoral and antimetastatic efficiency in Lewis lung carcinoma bearing mice. Ben Reguiga M; Bouquet C; Farinotti R; Bonhomme-Faivre L Life Sci; 2012 Oct; 91(17-18):843-51. PubMed ID: 23047021 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models. Springate CM; Jackson JK; Gleave ME; Burt HM Cancer Chemother Pharmacol; 2005 Sep; 56(3):239-47. PubMed ID: 15864591 [TBL] [Abstract][Full Text] [Related]
36. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models. Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925 [TBL] [Abstract][Full Text] [Related]
37. Ligand-conjugated mesoporous silica nanorattles based on enzyme targeted prodrug delivery system for effective lung cancer therapy. Sundarraj S; Thangam R; Sujitha MV; Vimala K; Kannan S Toxicol Appl Pharmacol; 2014 Mar; 275(3):232-43. PubMed ID: 24467950 [TBL] [Abstract][Full Text] [Related]
38. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer. Qu MH; Zeng RF; Fang S; Dai QS; Li HP; Long JT Int J Pharm; 2014 Oct; 474(1-2):112-22. PubMed ID: 25138252 [TBL] [Abstract][Full Text] [Related]
39. Antitumor activity of hydrophilic Paclitaxel copolymer prodrug using locoregional delivery in human orthotopic non-small cell lung cancer xenograft models. Zou Y; Fu H; Ghosh S; Farquhar D; Klostergaard J Clin Cancer Res; 2004 Nov; 10(21):7382-91. PubMed ID: 15534115 [TBL] [Abstract][Full Text] [Related]
40. The antitumor effects of CIK cells combined with docetaxel against drug-resistant lung adenocarcinoma cell line SPC-A1/DTX in vitro and in vivo. Liu P; Chen L; Huang X Cancer Biother Radiopharm; 2009 Feb; 24(1):91-8. PubMed ID: 19243251 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]